Am. J. Respir. Crit. Care Med., Volume 160, Number 5, November 1999, 1516-1524

Relationship of Cellular Transmigration and Airway Response after Allergen Challenge

IKEADI MAURICE NDUKWU, EDWARD T. NAURECKAS, CHRISTOPHER MAXWELL, MICHAEL WALDMAN, and ALAN R. LEFF

Section of Pulmonary and Critical Care Medicine, and the Committees on Cellular Physiology and Clinical Pharmacology, Division of the Biological Sciences, The University of Chicago, Chicago, Illinois

We examined the relationship between eosinophil migration into the bronchoalveolar space and change in FEV₁ after endobronchial allergen challenge (EBAC) in atopic asthmatic (AA) and atopic nonasthmatic (ANA) subjects. The purpose of this study was to obtain continuous, intrasubject controlled assessment of the relationship between cell migration in control and allergen-challenged segments in the same individuals over 96 h. In AA subjects, the eosinophil (Eos) count in the bronchoalveolar lavage fluid (BALF) increased from a baseline of 7,896 ± 3,865 to 416,476 ± 231,012 Eos/ml by 72 h (p = 0.001) in the challenged segment post-EBAC. For ANA subjects, the postsegmental challenge count was 29,874 ± 474 Eos/ml (p = 0.03 versus baseline and p < 0.05 AA peak versus ANA peak). In both groups, there was a comparable decrease in peripheral blood eosinophil count beginning 5 h after challenge, which resolved at 24 h. In AA subjects, 416,476 ± 231,012 Eos/ml was obtained from the allergen-challenged segment and 23,522 ± 8,298 Eos/ml was obtained from the sham-challenged segment (p < 0.001) at 72 h. In contrast, there was no difference in the Eos count obtained from the BALF between the antigen- and sham-challenged segments of ANA subjects. We also found that increased airway neutrophils were present in equal numbers in allergen-challenged and sham-challenged segments in both AA and ANA subjects. We conclude that augmented eosinophil migration after EBAC is a characteristic of atopic asthma and is not present in atopic subjects who do not have asthma. We find that BAL eosinophilia in ANA patients as well as neutrophilia in both ANA and AA subjects are nonspecific consequences of bronchoscopy. Finally, we find no relationship between specific airway eosinophil migration into the BALF and FEV₁ < 72 h after challenge; however, at 96 h, there is a substantial decrease in FEV₁ that accompanies BALF eosinophilia. Ndukwu IM, Naureckas ET, Maxwell C, Waldman M, Leff AR. Relationship of cellular transmigration and airway response after allergen challenge.

This article has been cited by other articles:

				M. E. Monzon, D. Manzanares, N. Schmid, S. M. Casalino-Matsuda, and R. M. Forteza Hyaluronidase Expression and Activity Is Regulated by Pro-Inflammatory Cytokines in Human Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 289 - 295. [Abstract] [Full Text] [PDF]

				P. J. Oldenburg and S. J. Mustafa Involvement of Mast Cells in Adenosine-Mediated Bronchoconstriction and Inflammation in an Allergic Mouse Model J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 319 - 324. [Abstract] [Full Text] [PDF]

				H. IIJIMA, A. DUGUET, S.-Y. EUM, Q. HAMID, and D. H. EIDELMAN Nitric Oxide and Protein Nitration are Eosinophil Dependent in Allergen-Challenged Mice Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1233 - 1240. [Abstract] [Full Text]

				H. Sano, X. Zhu, A. Sano, E. E. Boetticher, T. Shioya, B. Jacobs, N. M. Munoz, and A. R. Leff Extracellular Signal-Regulated Kinase 1/2-Mediated Phosphorylation of Cytosolic Phospholipase A2 Is Essential for Human Eosinophil Adhesion to Fibronectin J. Immunol., March 1, 2001; 166(5): 3515 - 3521. [Abstract] [Full Text] [PDF]